Antiarrhythmic Drugs [electronic resource] : Mechanisms of Antiarrhythmic and Proarrhythmic Actions /

Management and prevention of tachyarrhythmias, especially of serious ventricular arrhythmias after myocardial infarction, is still a major problem. Large-scale evidence suggests an increased harm induced by antiarrhythmic drugs in the presence of organic heart disease although they effectively suppress spontaneous arrhythmias. This increased risk has been linked to their proarrhythmic potential and to possible interactions by ischaemia. However, the mechanisms by which antiarrhythmic drugs exert their antiarrhythmic and proarrhythmic actions are still poorly understood. Therefore, it was a time to present an update on the mechanisms of antiarrhythmic and proarrhythmic action of drugs which act on the electrophysiological properties of the heart. World renowned electrophysiologists as well as clinicians have joint to address important topics which range from the effect of antiarrhythmic drugs on single channels and on arrhythmia models to the clinical arena.

Na minha lista:
Detalhes bibliográficos
Principais autores: Breithardt, Günter. editor., Borggrefe, Martin. editor., Camm, A. John. editor., Shenasa, Mohammad. editor., Haverkamp, Wilhelm. editor., Hindricks, Gerhard. editor., SpringerLink (Online service)
Formato: Texto biblioteca
Idioma:eng
Publicado em: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 1995
Assuntos:Medicine., Pharmacology., Cardiology., Medicine & Public Health., Pharmacology/Toxicology.,
Acesso em linha:http://dx.doi.org/10.1007/978-3-642-85624-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
Descrição
Resumo:Management and prevention of tachyarrhythmias, especially of serious ventricular arrhythmias after myocardial infarction, is still a major problem. Large-scale evidence suggests an increased harm induced by antiarrhythmic drugs in the presence of organic heart disease although they effectively suppress spontaneous arrhythmias. This increased risk has been linked to their proarrhythmic potential and to possible interactions by ischaemia. However, the mechanisms by which antiarrhythmic drugs exert their antiarrhythmic and proarrhythmic actions are still poorly understood. Therefore, it was a time to present an update on the mechanisms of antiarrhythmic and proarrhythmic action of drugs which act on the electrophysiological properties of the heart. World renowned electrophysiologists as well as clinicians have joint to address important topics which range from the effect of antiarrhythmic drugs on single channels and on arrhythmia models to the clinical arena.